Gilead And Teva Drug Buyers Lose Bid For New Antitrust Trial
A California federal judge on Wednesday refused to grant HIV medication purchasers a new trial following a jury's verdict clearing Gilead and Teva in a $3.6 billion antitrust case claiming they...To view the full article, register now.
Already a subscriber? Click here to view full article